Edwards Lifesciences Corp. (EW)
85.25
-0.95
(-1.10%)
USD |
NYSE |
Dec 31, 16:00
85.16
-0.09
(-0.11%)
Pre-Market: 20:00
Edwards Lifesciences Free Cash Flow: 799.60M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp. | 3.824B |
| Abbott Laboratories | 6.917B |
| Stryker Corp. | 4.073B |
| Globus Medical, Inc. | 569.94M |
| Pulse Biosciences, Inc. | -48.79M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 573.70M |
| Cash from Investing (Quarterly) | -661.50M |
| Cash from Financing (Quarterly) | -506.40M |
| Free Cash Flow Per Share (Quarterly) | 0.8813 |
| Free Cash Flow to Equity (Quarterly) | 518.50M |
| Free Cash Flow to Firm (Quarterly) | 516.20M |
| Free Cash Flow Yield | 1.60% |